Repaglinide Teva

Medicinal product

(Invented) name

Repaglinide Teva

Active substance (s)

Repaglinidas

Strength

0,5 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

A10BX02, Repaglinide

Marketing authorisation holder

Teva B.V., Nyderlandai

Date of authorisation

2009-06-29

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

10(1)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Tablet	1 vnt.
Repaglinidas	0,5 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
37030	50649	1050649	lizdinė plokštelė	N30		Receptinis	EU/1/09/530/001	Netiekiama	-	-	No	-	-
37031	50650	1050650	lizdinė plokštelė	N90		Receptinis	EU/1/09/530/002	Netiekiama	-	-	No	-	-
37032	50651	1050651	lizdinė plokštelė	N120		Receptinis	EU/1/09/530/003	Netiekiama	-	-	No	-	-
37033	50652	1050652	lizdinė plokštelė	N270		Receptinis	EU/1/09/530/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2009-06-29	Registruotas